Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Afya ( (AFYA) ) is now available.
On December 17, 2025, Afya Limited announced that Mrs. Maria Tereza Azevedo will resign from the Board of Directors effective December 31, 2025. The company acknowledged her significant contributions and expressed gratitude for her service. Afya’s Board, composed of representatives from Bertelsmann SE&Co. KGaA, the Esteves family, and independent members, maintains a diverse skill set expected to continue strengthening the company’s governance and decision-making framework.
The most recent analyst rating on (AFYA) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors contributing to its score. The company’s robust revenue growth, profitability, and strategic achievements in the earnings call highlight its potential for future success. Technical analysis indicates some bearish momentum, but valuation metrics suggest the stock is reasonably priced.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya Limited is a prominent medical education group in Brazil, offering a comprehensive physician-centric ecosystem. The company supports medical students and professionals throughout their careers, from education and residency preparation to medical practice solutions, enhancing healthcare services across the nation.
Average Trading Volume: 99,833
Technical Sentiment Signal: Sell
Current Market Cap: $1.32B
Learn more about AFYA stock on TipRanks’ Stock Analysis page.